Craving reduction: Especially effective against sweets and high-carb urges
South America presents a different access pattern, because Brazil saw strong GLP-1 demand growth after patent expiry, and Argentina already had domestic semaglutide biosimilar activity with partial insurer reimbursement for documented diabetes treatment
In phase 2 clinical research, retatrutide was studied for obesity and produced significant weight reduction over 24 and 48 weeks
You're on a GLP-1 medication, and mornings feel different now
These effects go away when you stop taking Ozempic, which could make you hungrier and make you gain weight
While this is helpful in preventing heart attacks, it also increases the risk of bleeding, especially if you take other medications or have underlying health issues